Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Immunisation for herpes zoster: current status.

Cunningham AL, Litt JC, Macintyre CR.

Med J Aust. 2014 Mar 17;200(5):243-4. No abstract available.

PMID:
24641130
2.

Rates of hospitalisation for herpes zoster may warrant vaccinating Indigenous Australians under 70.

Sheel M, Beard FH, Dey A, Macartney K, McIntyre PB.

Med J Aust. 2017 Nov 6;207(9):395-396. No abstract available.

PMID:
29092706
3.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
4.

Zoster vaccine protects against shingles.

[No authors listed]

BMJ. 2013 Apr 17;346:f2389. doi: 10.1136/bmj.f2389. No abstract available.

PMID:
23596220
5.

Vaccine against herpes zoster halves incidence in older people, finds study.

Ramsey S.

BMJ. 2013 Apr 12;346:f2349. doi: 10.1136/bmj.f2349. No abstract available.

PMID:
23585074
6.

Herpes zoster vaccine (Zostavax) revisited.

[No authors listed]

Med Lett Drugs Ther. 2010 May 31;52(1339):41. No abstract available.

PMID:
20508580
7.

Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium.

Annemans L, Bresse X, Gobbo C, Papageorgiou M.

J Med Econ. 2010;13(3):537-51. doi: 10.3111/13696998.2010.502854.

PMID:
20707768
8.

[The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].

Afonina NM, Mikheeva IV.

Ter Arkh. 2013;85(11):130-3. Review. Russian.

PMID:
24432613
9.

The looming rash of herpes zoster and the challenge of adult immunization.

Donahue JG, Belongia EA.

Ann Intern Med. 2010 May 4;152(9):609-11. doi: 10.7326/0003-4819-152-9-201005040-00011. No abstract available.

PMID:
20439578
10.

Vaccine approved for shingles in older people.

[No authors listed]

FDA Consum. 2006 Sep-Oct;40(5):38-9.

11.

The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.

Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D.

Can Commun Dis Rep. 2007 Nov 1;33(11):1-15. English, French. No abstract available.

12.

Importance of vaccination against herpes zoster.

Evans DL; Advisory Committee on Immunization Programs-United States Centers for Disaese Control and Prevention.

J Am Osteopath Assoc. 2010 Feb;110(2 Suppl 1):S14-20. No abstract available.

PMID:
20207984
13.

Vaccine cuts by half the risk of developing shingles.

[No authors listed]

Mayo Clin Health Lett. 2007 Oct;25(10):4. No abstract available.

PMID:
18229411
14.

Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.

Gelb LD.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S18-21. Review.

PMID:
19553631
15.

Herpes zoster vaccination: benefits and barriers.

Komara FA.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S22-4. Review.

PMID:
19553633
16.

Varicella virus and the herpes zoster vaccine. A review of Zostavax and the new AFIP recommendations.

Ebede TL, Zippin JH.

J Drugs Dermatol. 2008 Dec;7(12):1173-6. No abstract available.

PMID:
19137773
17.

How should nursing homes use vaccine to prevent zoster?

Drinka PJ.

J Am Med Dir Assoc. 2007 Sep;8(7):419-20. No abstract available.

PMID:
17845943
18.

[Herpes zoster and postherpetic neuralgia: advantages of the vaccination].

CaƱada JL.

Rev Esp Quimioter. 2009 Nov;22 Suppl 1:19-21. Review. Spanish. No abstract available.

19.

[Vaccination from age 50 makes sense].

Panknin HT, Heppner HJ.

Med Monatsschr Pharm. 2015 Nov;38(11):473-5. German. No abstract available.

PMID:
26742216
20.

Shingles vaccine.

Willison CB, Morrison LK, Mendoza N, Tyring SK.

Expert Opin Biol Ther. 2010 Apr;10(4):631-8. doi: 10.1517/14712591003623203. Review.

PMID:
20113211

Supplemental Content

Support Center